DICE Therapeutics (DICE) PEG Ratio

Price: $47.55
Market Cap: $2.27B
Avg Volume: 1.75M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0
52W Range: $15.08-47.9
Website: DICE Therapeutics

PEG Ratio Summary

  • DICE Therapeutics's trailing twelve month (TTM) PEG ratio is -0.23.
  • DICE Therapeutics's annual PEG ratio as of today is 0.32.
  • DICE Therapeutics's quarterly PEG ratio is -0.21.

What is the PEG Ratio?

The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.

How is the PEG Ratio calculated?

The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:

PEG Ratio = (P/E Ratio) / (EPS Growth Rate)

This helps investors to determine a stock's value while considering the company's earnings growth.

Related Metrics

Other important metrics to assess DICE Therapeutics's financial health include:

  • P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
    • Annual: -15.05
    • Quarterly: -15.78
    • TTM: -22.94
  • P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
    • Annual: 0.00
    • Quarterly: 0.00
    • TTM: 0.00
  • P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
    • Annual: -6.55
    • Quarterly: 4.23
    • TTM: -9.99
  • P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
    • Annual: -19.11
    • Quarterly: -76.92
    • TTM: -29.13

These metrics provide insights into DICE Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

TTM PEG Ratio

-0.23

Annual PEG Ratio

0.32

Quarterly PEG Ratio

-0.21

DICE Therapeutics Historical PEG Ratio

0.470.470.320.320.170.170.020.02-0.14-0.14-0.29-0.29-0.44-0.44PEG Ratio0.32-0.02-0.440.0020202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Historical P/E Ratio

0.000.00-20.00-20.00-40.00-40.00-60.00-60.00-80.00-80.00P/E Ratio-15.05-6.47-36.07-66.0920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Historical P/S Ratio

1000.001000.00800.00800.00600.00600.00400.00400.00200.00200.000.000.00P/S Ratio0.00278.61992.80148.3620202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Historical P/B Ratio

0.000.00-7.00-7.00-14.00-14.00-21.00-21.00-28.00-28.00-35.00-35.00P/B Ratio-6.55-3.02-16.12-28.9220202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

Historical P/CF Ratio

0.000.00-10.00-10.00-20.00-20.00-30.00-30.00-40.00-40.00-50.00-50.00-60.00-60.00P/CF Ratio-19.11-7.98-41.43-52.5720202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023

DICE Therapeutics Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2022.

Year PEG Ratio P/E Ratio P/S Ratio P/B Ratio P/CF Ratio
2022 0.32 -15.05 0.00 -6.55 -19.11
2021 -0.02 -6.47 278.61 -3.02 -7.98
2020 -0.44 -36.07 992.80 -16.12 -41.43
2019 0.00 -66.09 148.36 -28.92 -52.57

Related Metrics

Explore detailed financial metrics and analysis for DICE.